VivoSim Labs (VIVS) EBT Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
VivoSim Labs (VIVS) EBT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -115.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 80.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -450.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -162.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 5,201.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -14,710.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 51.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.77 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -751,066.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -751,066.00 |
| Mar 31, 2026 | -171,495.00 |
| Dec 31, 2025 | 401,250.00 |
| Sep 30, 2025 | -58,548.00 |
| Jun 30, 2025 | 88,545.00 |
| Mar 31, 2025 | 432,745.00 |
| Dec 31, 2024 | 5.77 Mn |
| Jun 30, 2024 | -318,523.00 |
| Mar 31, 2024 | -580,741.00 |
| Dec 31, 2023 | -6.96 Mn |
| Mar 31, 2023 | -456,519.00 |
| Dec 31, 2019 | -90,066.00 |
| Sep 30, 2019 | 7,882.00 |
| Jun 30, 2019 | 12,949.00 |
| Mar 31, 2019 | -35,370.00 |
| Dec 31, 2018 | -13,738.00 |
| Sep 30, 2018 | 7,925.00 |
| Jun 30, 2018 | -5,579.00 |
| Mar 31, 2018 | 63,393.00 |
| Dec 31, 2017 | 15,669.00 |